June 6th 2023
By Kristie L. Kahl
Tumor treating fields therapy “is a potentially paradigm-shifting new treatment modality” for metastatic non-small cell lung cancer, says Dr. Ticiana Leal.
June 6th 2023
By Kyle Doherty
Patients with advanced-stage classic Hodgkin lymphoma had a longer progression-free survival rate with Opdivo plus AVD, a chemotherapy regimen, compared with Adcetris plus AVD.
June 6th 2023
By Kyle Doherty
June 6th 2023
By Mary Sansone
Lasting guilt gets no one anywhere — especially when it comes to cancer.
June 6th 2023
By Lindsay Fischer
Jemperli plus carboplatin and paclitaxel also helped patients with early endometrial cancer maintain their health-related quality of life throughout follow-up.
June 6, 2023 5:00 PM
By Mary Sansone
June 5, 2023 5:00 PM
By Ron Cooper
June 2, 2023 5:00 PM
By Debbie Legault
June 1, 2023 9:00 PM
By Linda Cohen
May 12, 2023 7:00 PM
By Bryana Tanner
May 11, 2023 9:00 PM
By Robert Trebor
May 8, 2023 9:00 PM
By Denise Sirchie
May 4, 2023 1:00 PM
By Chester Freeman